表紙:非経口栄養の北米市場:栄養タイプ別、国別、成長性、COVID-19による影響分析と予測(2021年~2027年)
市場調査レポート
商品コード
1029714

非経口栄養の北米市場:栄養タイプ別、国別、成長性、COVID-19による影響分析と予測(2021年~2027年)

North America Parenteral Nutrition Market By Nutrient Type, By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

出版日: | 発行: KBV Research | ページ情報: 英文 57 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
非経口栄養の北米市場:栄養タイプ別、国別、成長性、COVID-19による影響分析と予測(2021年~2027年)
出版日: 2021年08月31日
発行: KBV Research
ページ情報: 英文 57 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の非経口栄養剤の市場規模は、予測期間(2021年~2027年)に7.3%のCAGRで成長すると予測されています。頭頸部がん、食道がん、クローン病、潰瘍性大腸炎、胃がん、喉頭がんなど、さまざまな疾患の増加により、今後数年間、同市場の成長が促進されると予測されています。ただし、投与時の感染リスクの高さや、患者の経腸栄養志向の高まりなどが、市場成長を阻む要因となっています。

同地域には、より優れた技術を開発するために、高額の投資を行っている大手企業が集積しており、北米市場に新たな機会をもたらしています。また、高齢人口の急増や低体重児出産の増加などの要因により、同地域市場では非経口栄養製品の需要が増加すると考えられています。

当レポートは、北米の非経口栄養剤市場について調査しており、市場の動向、影響を与える要因、栄養素タイプ・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 市場の範囲と調査手法

第2章 市場概要

  • イントロダクション
  • 市場に影響を与える主な要因

第3章 栄養素タイプ別:北米の非経口栄養市場

  • 単回投与アミノ酸溶液
  • 非経口脂質エマルジョン
  • 炭水化物
  • 微量元素
  • その他

第4章 国別:北米の非経口栄養市場

  • 米国
  • カナダ
  • メキシコ
  • その他

第5章 企業プロファイル

  • Vifor Pharma Management Ltd.
  • Baxter International, Inc.
  • Allergan PLC(AbbVie)
  • B. Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • Grifols S.A.
  • Pfizer, Inc.
  • ICU Medical, Inc.
  • Anhui Medipharm Co., Ltd.
  • Aculife Healthcare Private Limited
図表

LIST OF TABLES

  • TABLE 1 North America Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 2 North America Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 3 North America Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 4 North America Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 5 North America Single Dose Amino Acid Solution Market by Country, 2017 - 2020, USD Million
  • TABLE 6 North America Single Dose Amino Acid Solution Market by Country, 2021 - 2027, USD Million
  • TABLE 7 North America Parenteral Lipid Emulsion Market by Country, 2017 - 2020, USD Million
  • TABLE 8 North America Parenteral Lipid Emulsion Market by Country, 2021 - 2027, USD Million
  • TABLE 9 North America Carbohydrates Market by Country, 2017 - 2020, USD Million
  • TABLE 10 North America Carbohydrates Market by Country, 2021 - 2027, USD Million
  • TABLE 11 North America Trace Elements Market by Country, 2017 - 2020, USD Million
  • TABLE 12 North America Trace Elements Market by Country, 2021 - 2027, USD Million
  • TABLE 13 North America Other Nutrient Type Market by Country, 2017 - 2020, USD Million
  • TABLE 14 North America Other Nutrient Type Market by Country, 2021 - 2027, USD Million
  • TABLE 15 North America Parenteral Nutrition Market by Country, 2017 - 2020, USD Million
  • TABLE 16 North America Parenteral Nutrition Market by Country, 2021 - 2027, USD Million
  • TABLE 17 US Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 18 US Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 19 US Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 20 US Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 21 Canada Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 22 Canada Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 23 Canada Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 24 Canada Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 25 Mexico Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 26 Mexico Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 27 Mexico Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 28 Mexico Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 29 Rest of North America Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 30 Rest of North America Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 31 Rest of North America Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 32 Rest of North America Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 33 Key Information - Vifor Pharma Management Ltd.
  • TABLE 34 Key Information - Baxter International, Inc.
  • TABLE 35 Key Information - Allergan PLC
  • TABLE 36 key Information - B. Braun Melsungen AG
  • TABLE 37 key information - Fresenius SE & Co. KGaA
  • TABLE 38 key information - Grifols S.A.
  • TABLE 39 Key Information - Pfizer, Inc.
  • TABLE 40 key information - ICU Medical, Inc.
  • TABLE 41 Key Information - Anhui Medipharm Co., Ltd.
  • TABLE 42 Key Information - ACULIFE HEALTHCARE PRIVATE LIMITED

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Recent strategies and developments: Baxter International, Inc.
目次

The North America Parenteral Nutrition Market would witness market growth of 7.3% CAGR during the forecast period (2021-2027).

The administration of parenteral drugs offers the advantages of rapid action and lower dose delivery that are helpful in the prevention of different negative effects due to dietary imbalances, hence boosting the development of parenteral nutritional products. In addition, various kinds of diseases like head & neck cancer, esophageal cancer, Crohn's, ulcerative colitis, gastric cancer, and laryngeal cancer can have an impact on oral food consumption among the patients. Due to their increasing occurrence, the parenteral nutrition market is expected to be propelled in the upcoming years. Though, some of the factors such as the huge risk of infection at the time of administration and the surge in the inclination of patients towards enteral nutrition pose barriers to the growth of the parenteral nutrition market.

The region is home to some of the leading market players, hence creating new growth avenues for the North American parenteral nutrition market. These players are also investing a high amount in the investment to develop better techniques. In addition, factors such as the rapid increment in the geriatric population and the increase in premature births around the world are estimated to boost the demand for parenteral nutrition products in the regional market.

Moreover, the surge in the number of metabolic disorders along with chronic diseases such as diabetes is one of the main factors fueling the growth of the parenteral nutrition market. The majority of individuals in the region are living an unhealthy lifestyle that could augment the demand for parenteral nutrition in the regional market.

The US market dominated the North America Trace Elements Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $347.2 million by 2027. The Canada market is showcasing a CAGR of 12% during (2021 - 2027). Additionally, The Mexico market would witness a CAGR of 11.1% during (2021 - 2027).

Based on Nutrient Type, the market is segmented into Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vifor Pharma Management Ltd., Baxter International, Inc., Allergan PLC (AbbVie), B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Grifols S.A., Pfizer, Inc., ICU Medical, Inc., Anhui Medipharm Co., Ltd. and Aculife Healthcare Private Limited.

Scope of the Study

Market Segments covered in the Report:

By Nutrient Type

  • Single Dose Amino Acid Solution
  • Parenteral Lipid Emulsion
  • Carbohydrates
  • Trace Elements,
  • Vitamins & Minerals

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled

  • Vifor Pharma Management Ltd.
  • Baxter International, Inc.
  • Allergan PLC (AbbVie)
  • B. Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • Grifols S.A.
  • Pfizer, Inc.
  • ICU Medical, Inc.
  • Anhui Medipharm Co., Ltd.
  • Aculife Healthcare Private Limited

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 North America Parenteral Nutrition Market, by Nutrient Type
    • 1.4.2 North America Parenteral Nutrition Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 COVID-19 Impact
      • 2.1.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. North America Parenteral Nutrition Market by Nutrient Type

  • 3.1 North America Single Dose Amino Acid Solution Market by Country
  • 3.2 North America Parenteral Lipid Emulsion Market by Country
  • 3.3 North America Carbohydrates Market by Country
  • 3.4 North America Trace Elements Market by Country
  • 3.5 North America Other Nutrient Type Market by Country

Chapter 4. North America Parenteral Nutrition Market by Country

  • 4.1 US Parenteral Nutrition Market
    • 4.1.1 US Parenteral Nutrition Market by Nutrient Type
  • 4.2 Canada Parenteral Nutrition Market
    • 4.2.1 Canada Parenteral Nutrition Market by Nutrient Type
  • 4.3 Mexico Parenteral Nutrition Market
    • 4.3.1 Mexico Parenteral Nutrition Market by Nutrient Type
  • 4.4 Rest of North America Parenteral Nutrition Market
    • 4.4.1 Rest of North America Parenteral Nutrition Market by Nutrient Type

Chapter 5. Company Profiles

  • 5.1 Vifor Pharma Management Ltd.
    • 5.1.1 Company Overview
    • 5.1.2 Financial Analysis
    • 5.1.3 Research & Development Expenses
  • 5.2 Baxter International, Inc.
    • 5.2.1 Company Overview
    • 5.2.2 Financial Analysis
    • 5.2.3 Regional Analysis
    • 5.2.4 Research & Development Expense
    • 5.2.1 Recent strategies and developments:
      • 5.2.1.1 Partnerships, Collaborations, and Agreements:
      • 5.2.1.2 Product Launches and Product Expansions:
      • 5.2.1.3 Approvals and Trails:
  • 5.3 Allergan PLC (AbbVie)
    • 5.3.1 Company Overview
    • 5.3.2 Financial Analysis
    • 5.3.3 Regional Analysis
    • 5.3.4 Research & Development Expense
  • 5.4 B. Braun Melsungen AG
    • 5.4.1 Company Overview
    • 5.4.2 Financial Analysis
    • 5.4.3 Segmental and Regional Analysis
    • 5.4.4 Research & Development Expenses
  • 5.5 Fresenius SE & Co. KGaA
    • 5.5.1 Company Overview
    • 5.5.2 Financial Analysis
    • 5.5.3 Segmental and Regional Analysis
    • 5.5.4 Research & Development Expenses
  • 5.6 Grifols S.A.
    • 5.6.1 Company Overview
    • 5.6.2 Financial Analysis
    • 5.6.3 Segmental and Regional Analysis
    • 5.6.4 Research & Development Expense
  • 5.7 Pfizer, Inc.
    • 5.7.1 Company Overview
    • 5.7.2 Financial Analysis
    • 5.7.3 Regional Analysis
    • 5.7.4 Research & Development Expenses
  • 5.8 ICU Medical, Inc.
    • 5.8.1 Company Overview
    • 5.8.2 Recent strategies and developments:
      • 5.8.2.1 Partnerships, Collaborations, and Agreements:
  • 5.9 Anhui Medipharm Co., Ltd.
    • 5.9.1 Company Overview
  • 5.10. Aculife Healthcare Private Limited
    • 5.10.1 Company Overview